205 related articles for article (PubMed ID: 27094683)
21. The Hippo pathway in intestinal regeneration and disease.
Hong AW; Meng Z; Guan KL
Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
[TBL] [Abstract][Full Text] [Related]
22. Stem/progenitor cells and reprogramming (plasticity) mechanisms in liver, biliary tree, and pancreas.
Reid LM
Hepatology; 2016 Jul; 64(1):4-7. PubMed ID: 27102721
[No Abstract] [Full Text] [Related]
23. Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.
Rouleau C; Pores Fernando AT; Hwang JH; Faure N; Jiang T; White EA; Roberts TM; Schaffhausen BS
J Virol; 2016 Aug; 90(16):7032-7045. PubMed ID: 27194756
[TBL] [Abstract][Full Text] [Related]
24. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
25. YAP and TAZ in epithelial stem cells: A sensor for cell polarity, mechanical forces and tissue damage.
Elbediwy A; Vincent-Mistiaen ZI; Thompson BJ
Bioessays; 2016 Jul; 38(7):644-53. PubMed ID: 27173018
[TBL] [Abstract][Full Text] [Related]
26. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
27. YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.
Guerrant W; Kota S; Troutman S; Mandati V; Fallahi M; Stemmer-Rachamimov A; Kissil JL
Cancer Res; 2016 Jun; 76(12):3507-19. PubMed ID: 27216189
[TBL] [Abstract][Full Text] [Related]
28. Hippo signaling in the kidney: the good and the bad.
Wong JS; Meliambro K; Ray J; Campbell KN
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F241-8. PubMed ID: 27194720
[TBL] [Abstract][Full Text] [Related]
29. Manipulating the Hippo-Yap signal cascade in stem cells for heart regeneration.
Cai WF; Wang L; Liu GS; Zhu P; Paul C; Wang Y
Ann Palliat Med; 2016 Apr; 5(2):125-34. PubMed ID: 27121740
[TBL] [Abstract][Full Text] [Related]
30. HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.
Kudryashova TV; Goncharov DA; Pena A; Kelly N; Vanderpool R; Baust J; Kobir A; Shufesky W; Mora AL; Morelli AE; Zhao J; Ihida-Stansbury K; Chang B; DeLisser H; Tuder RM; Kawut SM; Silljé HH; Shapiro S; Zhao Y; Goncharova EA
Am J Respir Crit Care Med; 2016 Oct; 194(7):866-877. PubMed ID: 27119551
[TBL] [Abstract][Full Text] [Related]
31. Context-dependent switch in chemo/mechanotransduction via multilevel crosstalk among cytoskeleton-regulated MRTF and TAZ and TGFβ-regulated Smad3.
Speight P; Kofler M; Szászi K; Kapus A
Nat Commun; 2016 May; 7():11642. PubMed ID: 27189435
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
[TBL] [Abstract][Full Text] [Related]
33. YAP controls transcriptional elongation through CKD9 recruitment for proximal pause release: "Hippo-thetical", new therapeutic targets?
Kyritsi F; Price DK; Figg WD
Cancer Biol Ther; 2016 Jun; 17(6):592-4. PubMed ID: 27149279
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations.
Sheffield BS; Lorette J; Shen Y; Marra MA; Churg A
Arch Pathol Lab Med; 2016 May; 140(5):391. PubMed ID: 27128293
[No Abstract] [Full Text] [Related]
35. In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer.
Kim MH; Kim MH; Kim KS; Park MJ; Jeong JH; Park SW; Ji YH; Kim KI; Lee TS; Ryu PY; Kang JH; Lee YJ
Int J Oncol; 2016 Jun; 48(6):2277-86. PubMed ID: 27098303
[TBL] [Abstract][Full Text] [Related]
36. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
[TBL] [Abstract][Full Text] [Related]
37. Poly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells.
Li F; Bullough KZ; Vashisht AA; Wohlschlegel JA; Philpott CC
Mol Cell Biol; 2016 Aug; 36(16):2121-31. PubMed ID: 27215387
[TBL] [Abstract][Full Text] [Related]
38. The Roles of NDR Protein Kinases in Hippo Signalling.
Hergovich A
Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
[TBL] [Abstract][Full Text] [Related]
39. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
40. S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells.
Li Y; Kong F; Wang J; Hu E; Wang R; Liu J; Xiao Q; Zhang W; He D; Xiao X
Oncotarget; 2016 Jun; 7(25):38133-38142. PubMed ID: 27203549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
